DE60121303D1 - Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten - Google Patents

Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten

Info

Publication number
DE60121303D1
DE60121303D1 DE60121303T DE60121303T DE60121303D1 DE 60121303 D1 DE60121303 D1 DE 60121303D1 DE 60121303 T DE60121303 T DE 60121303T DE 60121303 T DE60121303 T DE 60121303T DE 60121303 D1 DE60121303 D1 DE 60121303D1
Authority
DE
Germany
Prior art keywords
cadpr
nicotinamide
treatment
medium
skin diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121303T
Other languages
English (en)
Other versions
DE60121303T2 (de
Inventor
Ltd Dermipsor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermipsor Ltd
Original Assignee
Dermipsor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermipsor Ltd filed Critical Dermipsor Ltd
Application granted granted Critical
Publication of DE60121303D1 publication Critical patent/DE60121303D1/de
Publication of DE60121303T2 publication Critical patent/DE60121303T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
DE60121303T 2000-01-11 2001-01-09 Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten Expired - Lifetime DE60121303T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13397600 2000-01-11
IL133976A IL133976A (en) 2000-01-11 2000-01-11 Agents for the treatment of skin disorders
PCT/IL2001/000017 WO2001051051A2 (en) 2000-01-11 2001-01-09 AGENTS, SUCH AS NICOTINAMIDE OR cADPR FOR THE TREATMENT OF SKIN DISORDERS

Publications (2)

Publication Number Publication Date
DE60121303D1 true DE60121303D1 (de) 2006-08-17
DE60121303T2 DE60121303T2 (de) 2007-06-14

Family

ID=11073692

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121303T Expired - Lifetime DE60121303T2 (de) 2000-01-11 2001-01-09 Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten

Country Status (11)

Country Link
US (1) US20030032617A1 (de)
EP (1) EP1259240B8 (de)
AT (1) ATE332136T1 (de)
AU (1) AU782558B2 (de)
CA (1) CA2396186C (de)
DE (1) DE60121303T2 (de)
DK (1) DK1259240T3 (de)
ES (1) ES2267706T3 (de)
HK (1) HK1051497A1 (de)
IL (2) IL133976A (de)
WO (1) WO2001051051A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
US7297480B2 (en) * 2001-06-28 2007-11-20 Dermtech International Method for detection of melanoma
CN1674921A (zh) 2002-06-20 2005-09-28 爱森皮肤医学股份有限公司 多羟基烷烃的脂肪酸酯和吡啶羧基衍生物的新型复合物
CA2492248A1 (en) * 2002-07-11 2004-01-22 Avikam Harel Composition and methods for the treatment of skin disorders
US7357950B2 (en) 2003-03-21 2008-04-15 Elizabeth Anne Mazzio Topical treatment for dyshidrosis (pompholyx) and dry skin disorders
US7666451B2 (en) 2003-03-21 2010-02-23 Elizabeth Anne Mazzio Method of treating dyshidrosis(pompholyx) and related dry skin disorders
GB0403041D0 (en) 2004-02-11 2004-03-17 Milner Anne J Induction of apoptosis
US7183057B2 (en) * 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
CN101217868A (zh) * 2005-05-10 2008-07-09 德米普瑟尔有限公司 用于皮肤护理的组合物和方法
JP2008540514A (ja) * 2005-05-10 2008-11-20 ダーミプソル リミテッド 過剰増殖表皮疾患の治療用組成物及び方法
US20070183995A1 (en) * 2006-02-09 2007-08-09 Conopco, Inc., D/B/A Unilever Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
GB0619860D0 (en) * 2006-10-06 2006-11-15 Birkeland Innovasjon As Treatment of insulin resistance and disorders associated therewith
US20080173558A1 (en) * 2007-01-22 2008-07-24 Contelanea Arvanitis Fragrance-emanating nasal mask device and method
WO2008137772A1 (en) * 2007-05-04 2008-11-13 Dermtech International Diagnosis of melanoma by nucleic acid analysis
EP2294216A4 (de) 2008-05-14 2011-11-23 Dermtech Int Diagnose von melanom und sonnenpigmentflecken mittels nukleinsäureanalyse
WO2010025341A2 (en) * 2008-08-28 2010-03-04 Dermtech International Determining age ranges of skin samples
JP6611099B2 (ja) * 2015-05-01 2019-11-27 ザ プロクター アンド ギャンブル カンパニー 皮膚の健康を改善する方法及びそのための組成物
US11013678B2 (en) 2015-06-29 2021-05-25 The Procter & Gamble Company Multi-component skin care product
US9833398B2 (en) 2016-01-11 2017-12-05 The Procter & Gamble Company Method of treating a skin condition and compositions therefor
CN114788791A (zh) 2017-06-23 2022-07-26 宝洁公司 用于改善皮肤外观的组合物和方法
KR102069088B1 (ko) * 2018-04-02 2020-01-22 양미경 탈모의 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학 또는 화장료 조성물
CA3102288A1 (en) 2018-07-03 2020-01-09 The Procter & Gamble Company Method of treating a skin condition
EP3948290A4 (de) 2019-03-26 2023-08-09 Dermtech, Inc. Neuartige genklassifikatoren und deren verwendungen bei hautkrebs
US11685766B2 (en) 2019-05-08 2023-06-27 Creighton University 14-3-3 targeting peptides for cancer treatment
WO2020227625A1 (en) * 2019-05-08 2020-11-12 Laura Hansen 14-3-3 targeting peptides for cancer treatment
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
WO2021247496A1 (en) 2020-06-01 2021-12-09 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
HU209067B (en) * 1991-12-30 1994-03-28 Tatar Process for the production of hair-fall moderating preparation
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
US6429218B1 (en) * 1997-05-19 2002-08-06 Joseph Scivoletto Method of controlling niacin concentration in lotion
US6248763B1 (en) * 1998-05-19 2001-06-19 Scivoletto Rosemarie Composition for treating skin conditions
USH2013H1 (en) * 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions
US6107349A (en) * 1998-04-16 2000-08-22 Mantynen; Philip R. Method and composition for treating psoriasis
DE29916231U1 (de) * 1999-09-15 2000-02-17 Renner Jobst Multivitamin- und -mineralpräparat

Also Published As

Publication number Publication date
US20030032617A1 (en) 2003-02-13
DK1259240T3 (da) 2006-10-30
WO2001051051A3 (en) 2002-06-27
IL133976A0 (en) 2001-04-30
AU782558B2 (en) 2005-08-11
DE60121303T2 (de) 2007-06-14
EP1259240B8 (de) 2007-05-09
EP1259240A2 (de) 2002-11-27
WO2001051051B1 (en) 2002-09-26
ATE332136T1 (de) 2006-07-15
AU2392901A (en) 2001-07-24
CA2396186C (en) 2011-03-22
WO2001051051A2 (en) 2001-07-19
ES2267706T3 (es) 2007-03-16
EP1259240B1 (de) 2006-07-05
IL133976A (en) 2006-09-05
IL150706A0 (en) 2003-02-12
CA2396186A1 (en) 2001-07-19
HK1051497A1 (en) 2003-08-08

Similar Documents

Publication Publication Date Title
DE60121303D1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
MY143795A (en) Tetrahydropyridoindole derivatives
ATE312635T1 (de) Ventilanordnung
DK1289517T3 (da) Farmaceutiske sammensætninger indeholdende cannabidiolderivater
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
WO2006120681A3 (en) Compositions and methods for skin care
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
ATE344670T1 (de) Synergistische kombination zur behandlung von kolorektalkarzinom
RS20050739A (en) Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
TNSN07203A1 (en) Pharmaceutical compositions for the treatment of cellulite
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
DE60310742D1 (de) Extrakt mit antitumoraler und antitoxischer wirkung
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
WO2004006887A3 (en) Composition and methods for the treatment of skin disorders
PL2066409T3 (pl) Zastosowanie ekstraktu z quinoa jako kosmetycznego i farmaceutycznego środka czynnego odchudzającego i/lub jako środka czynnego zapobiegającego tworzeniu się nowych tłuszczów w ludzkim ciele
WO2004030623A3 (en) Nitroxide radioprotector formulations and methods of use
TR199901385T2 (xx) Piperidin t�revleri.
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
PL355292A1 (en) Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics
IL156144A0 (en) Novel therapeutic use of a thienylcyclohexylamine derivative
TW200500073A (en) Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: HAREL, AVIKAM, TEL AVIV, IL

Inventor name: BLOCH, OLGA, PETACH TIKVA, IL

8364 No opposition during term of opposition